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urgently needed.[3] Nanomedicine rep-
resents a promising therapeutic strategy 
for addressing this major problem in the 
clinic, particularly in combating drug 
resistance in infectious diseases. Syn-
thetic antimicrobial polymers, such as 
amphiphilic and cationic polymers, have 
emerged as promising candidates for fur-
ther development as antimicrobial agents 
with decreased potential for development 
of resistance.[4–6]
Synthetic polymers possess the pow-
erful ability to be modified with multiple 
chemistries, active agents, and function-
alities. They can be endowed with intrinsic 
antimicrobial activity by mimicking chem-
istries and functions of antimicrobial pep-
tides, notably cationic moieties that interact 
with negatively charged bacterial cell walls, 
whilst hydrophobic counterparts can be 
used to facilitate membrane penetration or 
hydrophilic components to facilitate water-
solubility in a drug delivery setting.[7] In 
general, the cationic, amphiphilic polymers exhibit selectivity 
to bacterial targets through favorable electrostatic interactions 
between the polymer and the highly negatively charged bacte-
rial cell surface.[5] The further self-assembly of amphiphilic 
polymers into nanoparticles can also increase efficacy over 
small molecule drugs and linear polymers by exploiting mul-
tivalency of functional groups to enable higher cell recognition 
and binding capabilities, improved penetration through the 
cell membrane, and ultimately, higher antimicrobial activity.[8] 
In isolation, antimicrobial polymers can induce bacterial cell 
death through mechanisms such as membrane destabilization 
and lysis, inhibition of energy metabolism, impaired respiratory 
function, and apoptotic-like cell death. Importantly, therapeutic 
nanoparticles can be further functionalized with small molecule 
drugs to limit bacterial expression of resistance by imparting 
multimodal mechanisms of action, by expressing multiple anti-
microbial features that work synergistically.[9]
Usnic acid (UA) is a naturally occurring dibenzofuran deriv-
ative isolated from lichen, and demonstrates interesting biolog-
ical properties, including powerful antimicrobial action.[10] Of 
particular relevance, it has been shown to strongly inhibit the 
growth of a range of planktonic gram-positive bacteria species, 
such as multi-resistant strains of Staphylococcus aureus, Staphy-
lococcus epidermidis, Enterococcus faecalis, and Mycobacterium 
tuberculosis.[11,12] S. aureus is an opportunistic pathogen and a 
common cause of healthcare-associated infections, including 
Polymer–drug conjugates have received considerable attention over the 
last decades due to their potential for improving the clinical outcomes for a 
range of diseases. It is of importance to develop methods for their prepara-
tion that have simple synthesis and purification requirements but maintain 
high therapeutic efficacy and utilize macromolecules that can be cleared via 
natural excretory pathways upon breakdown. Herein, the combination of ring-
opening polymerization (ROP) and reversible addition−fragmentation chain-
transfer (RAFT) polymerization is described for the straightforward synthesis 
of amphiphilic, stimuli-responsive, biodegradable, and highly functionalizable 
hyperbranched polymers. These unimolecular nanoparticles demonstrate 
a versatile platform for the synthesis of polymer–drug conjugates owing to 
the inclusion of a Boc-protected polycarbonate moiety in either a block or 
random copolymer formation. A proof-of-concept study on the complexation 
of the poorly water-soluble antimicrobial drug usnic acid results in polymer-
drug complexes with powerful antimicrobial properties against gram-positive 
bacteria. Therefore, this work highlights the potential of amphiphilic and 
biodegradable hyperbranched polymers for antimicrobial applications.
Antimicrobial resistance (AMR) is a global problem, with infec-
tions caused by multidrug-resistant bacteria now reaching 
critical levels. The need for new antimicrobial agents is cur-
rently a well-documented and important issue relating to world 
health.[1,2] The World Health Organisation (WHO) has identi-
fied 12 species of bacteria for which new innovations and effec-
tive antimicrobial agents without pre-existing resistance are 
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. This is an open access article under the terms of the Creative 
Commons Attribution-NonCommercial License, which permits use, dis-
tribution and reproduction in any medium, provided the original work is 
properly cited and is not used for commercial purposes.
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skin infections (e.g., abscesses), respiratory infections (e.g., 
sinusitis), and food poisoning.[13] Significantly, S. aureus is one 
of the five most common causes of  hospital-acquired infec-
tions and is often the cause of wound infections following sur-
gery, and therefore it is crucial to develop new and effective 
strategies to combat this class of infection.[14] Unfortunately, 
despite its therapeutic potential, applications of UA have been 
limited by its poor solubility in water and its hepatotoxicity.[15,16]
Previously, we have demonstrated a facile and highly-
accessible route to a range of amphiphilic polymeric mate-
rials through a combined ring-opening polymerization (ROP) 
and reversible addition−fragmentation chain-transfer (RAFT) 
polymerization strategy.[17,18] Particularly, we have shown that the 
use of 2-hydroxyethyl methacrylate (HEMA) as a bifunctional 
initiator for the ROP step gives ready access to biodegradable 
macromonomers that can be polymerized into interesting final 
architectures, such as hyperbranched polymers (HBs).[19] HBs 
show great promise for drug delivery applications on account 
of their unimolecular nature (no critical aggregation concentra-
tion), small particle sizes (less than 50 nm), and their highly 
branched structure, which provides a high local density of 
functional groups for further functionalization with drugs.[20,21] 
While linear, cationic homopolymers possess antimicrobial 
activity through disruption of the bacteria cell membrane, they 
have limited potential for codelivery of a second drug due to 
their high water-solubility and lack of additional chemical han-
dles.[22] Formulation into polymeric nanoparticles can facilitate 
the inclusion and controlled delivery of small molecule drugs; 
however, the larger size and masking of charged groups can 
hinder their therapeutic performance.[23] On the contrary, the 
unique properties of HBs can combine the advantages of both 
strategies by ensuring accessibility and flexibility of the cationic 
groups in solution, while also providing a high density of func-
tional groups for attachment of additional therapeutics.
In previous work, we investigated the copolymerization 
of the pharmaceutically relevant lactide with a Boc-protected 
serinol-based cyclic carbonate monomer (tBSC) to produce 
a biodegradable material capable of further functionaliza-
tion,[24,25] demonstrated through the conjugation of a model 
chemotherapeutic drug doxorubicin and a novel nitric oxide 
photodonor moiety.[19,26] However, given the presence of the 
charged amine groups following the trifluoroacetic acid (TFA) 
deprotection step, we envisaged that these polymers could also 
be exploited for antimicrobial applications in a simple fashion. 
Specifically, through further complexation of the polymer parti-
cles with UA, we can achieve in a single step a powerful combi-
nation approach that can both improve the apparent solubility 
and bioactivity of the drug, and demonstrate a simple method 
to form polymer–drug complexes without the need for addi-
tional excipients.[27–29]
Based on this, in this work, we sought to investigate the 
potential of amphiphilic and biodegradable hyperbranched pol-
ymers for antimicrobial applications in combination with the 
powerful drug usnic acid. We were further interested to explore 
the effect of monomer distribution on drug complexation and 
antimicrobial performance by comparing particles synthesized 
using macromonomers of random or block copolymerized 
lactide and tBSC. The hyperbranched polymers were synthe-
sized incorporating a nonresponsive crosslinker, as well as 
investigating the inclusion of a disulfide-responsive crosslinker, 
which we hypothesized to be of interest for future studies with 
successful conjugates due to the potential of redox-responsive 
groups to counteract biofilm formation and drug resistance trig-
gered by the presence of endogenous oxidative reactions.[30,31] 
Lastly, the importance of water solubility of the final conjugates 
was explored by preparing two classes of HBs, comprising 
either 100 mol% of the biodegradable macromonomer or as a 10 
mol% copolymer with poly(ethylene glycol) methyl ether meth-
acrylate (PEGMA). The resultant polymer library was trans-
formed into cationic particles through Boc-deprotection using 
TFA, with subsequent complexation with usnic acid and was 
ultimately evaluated for their antimicrobial activity against wild 
type and drug resistant mutant strains of S. aureus. The overall 
synthetic strategy is depicted in Scheme 1.
A ring-opening polymerization method initiated by 2-hydrox-
yethyl methacrylate was employed in order to produce hydro-
phobic and functionalizable macromonomers amendable to 
further radical polymerization reactions. First, the Boc-pro-
tected cyclic carbonate monomer (tBSC) was synthesized in 
two steps starting from serinol as previously described, and 
fully characterized to confirm that no free alcohol groups 
remained.[19] d,l-Lactide (LA) was used as a comonomer due to 
its ubiquitous presence in the drug delivery field and to tune 
the hydrophobicity and degradation rates of the final macro-
molecules. As shown in Figure  1, two different macromono-
mers were synthesized targeting 15 repeat units of both the LA 
and tBSC, as either a random copolymer or as an A–B block 
copolymer, in order to investigate the influence of functional 
group placement. The ROPs were performed at room tem-
perature in anhydrous dichloromethane (DCM) with 1,8-diaz-
abicyclo(5.4.0)undec-7-ene (DBU) as organocatalyst. Each ROP 
step was complete within 10 min, reaching >99% conversion. 
1H NMR spectroscopy confirmed final DP values in good agree-
ment with feed ratios, indicating integrity of the ROP process 
(Figures S1 and S2, Supporting Information).
To produce nanoparticles, the two macromonomers, HEMA-
p(LA)15-co-p(tBSC)15 and HEMA-p(LA)15-b-p(tBSC)15 were then 
further polymerized into hyperbranched polymer structures 
using RAFT polymerization. This process allows for the semi-
controlled formation of dense, highly branched structures that 
form unimolecular nanoparticles in solution of sizes less than 
100 nm without the need for surfactants or formulation steps. 
The addition of a low molar ratio (<10%) of a bis-methacrylate 
crosslinker promotes the formation of hyperbranched poly-
mers, and in this work we were interested to investigate two 
different chemistries: the nondegradable and commercial eth-
ylene glycol dimethacrylate (EGDMA) and a redox responsive 
disulfide-containing bismethacrylate (DSDMA). Initially, the 
ROP macromonomers are hydrophobic and therefore have 
no solubility in aqueous environments; however, following 
removal of the Boc-protecting groups with TFA, the charged 
amine groups should increase the solubility. Based on this, the 
final variable we were interested to investigate was the influ-
ence of water-solubility on both drug loading and antimicrobial 
performance. To achieve this, HBs were formed from either 100 
mol% of the macromonomer or as a copolymer with 90 mol% 
PEGMA. In total eight HBs were synthesized combining the 
three variables, shown in Scheme 1 and Table 1.
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With the exception of the nature of the monomer feed 
and chemistry of the crosslinker, all other polymerization 
conditions were identical. 1H NMR spectroscopy and size-
exclusion chromatography (SEC) analysis confirmed the suc-
cessful attainment of eight unique hyperbranched polymer 
species (Figures S3–S10, Supporting Information). Due to 
the complex chemistry of the HBs resulting in multiple over-
lapping signals within the 1H NMR spectra, polymerization 
conversions were not able to be determined; however, almost 
complete consumption of the vinyl peaks (6.1 and 5.6 ppm) 
confirmed that the polymerization had taken place. This was 
further confirmed through SEC analysis of the final macromol-
ecules, which showed the presence of a relatively large mole-
cular weight species, with broad dispersities that are typical 
of hyperbranched polymer architectures (Figure  1, Table  1). 
Dynamic light scattering (DLS) measurements were performed 
in 0.5 m NaCl for the soluble PEGMA copolymers which con-
firmed particles with sizes ranging from 35 to 68 nm.
Macromol. Rapid Commun. 2020, 2000190
Scheme 1. The overall strategy for the polymer–drug complexes synthesized in this work.
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Following the successful synthesis of the base hyperbranched 
molecules, the Boc-protecting groups were removed to yield the 
free charged amine species (Figure  2). This reaction was per-
formed as previously reported using TFA in anhydrous DCM at 
0  °C to avoid degradation of the polyester/polycarbonate back-
bones.[19,26] The appearance of the ammonium peak by 1H NMR 
spectroscopy confirmed the unmasking of on average 50% of 
the amine groups (Figures S11–S18, Supporting Information). 
SEC analysis after deprotection showed no changes in the reten-
tion time or intensity of the polymer peaks indicating that no 
unwanted hydrolysis had occurred (Figure S19, Supporting Infor-
mation). Finally, zeta-potential measurements were performed 
on the deprotected HBs synthesized with EGDMA as representa-
tive samples. The two copolymers with PEGMA showed positive 
zeta potential values dependent on the macromonomer structure, 
with the random macromonomer showing an overall neutral 
charge (likely due to the sporadic arrangement of ammonium 
groups) and the block macromonomer showing an increase to 
+13.3 mV. As expected, the HBs formed from 100 mol% mac-
romonomer had a higher positive value due to the increased 
Macromol. Rapid Commun. 2020, 2000190
Table 1. SEC and DLS characterization of HBs 1–8.
Sample Structure of macromonomer Mn (SEC) ÐM (Mw/Mn) Dh (DLS)
HB1: PEGMA-p[HEMA-p(LA)-co-p(tBSC)] Random 37 kDa 2.3 50 nm
HB2: PEGMA-SS-p[HEMA-p(LA)-co-p(tBSC)] Random 107 kDa 1.2 35 nm
HB3: p[HEMA-p(LA)-co-p(tBSC)] Random 20 kDa 2.7 a)
HB4: SS-p[HEMA-p(LA)-co-p(tBSC)] Random 200 kDa 1.8 a)
HB5: PEGMA-p[HEMA-p(LA)-b-p(tBSC)] Block 32 kDa 1.3 44 nm
HB6: PEGMA-SS-p[HEMA-p(LA)-b-p(tBSC)] Block 52 kDa 2.1 68 nm
HB7: p[HEMA-p(LA)-b-p(tBSC)] Block 96 kDa 2.1 a)
HB8: SS-p[HEMA-p(LA)-b-p(tBSC)] Block 83 kDa 1.6 a)
a)not water-soluble.
Figure 1. A) Synthetic route towards the block copolymer macromonomer HEMA-p(LA)15-b-p(tBSC)15. B) Characterization of the purified products by 
1H NMR spectroscopy. c) Representative SEC traces for the block copolymer macromonomer HB series, and d) representative DLS data in 0.5 m NaCl 
for the water-soluble PEGMA copolymers.
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number of amine groups, with a zeta potential of approximately 
45 mV for both HBs (Table S1, Supporting Information).
Subsequently, the hydrophobic drug usnic acid was com-
plexed to the charged HBs through electrostatic interactions 
(Figure 2). The polymers and drug were sonicated for 10 min in 
water to facilitate dispersal of the drug throughout the polymer 
matrix. The complexes were purified to remove un-complexed 
UA through centrifugation and the supernatant recovered by 
lyophilization. Quantification of UA complexation was per-
formed using UV-vis analysis in dimethyl sulfoxide (DMSO) 
at 280 nm (Table  2). As expected, the HBs comprised of 100 
mol% macromonomer had a greater drug loading than those 
of the copolymers with PEGMA as a result of a greater number 
of available charged amine groups. Interestingly, it could also 
be seen that the block macromonomer structure could facili-
tate both a higher drug content and encapsulation efficiency 
than the random structure. This can perhaps be attributed to 
the multiple charged groups on usnic acid requiring interaction 
with multiple charges on the HBs, and thus more efficacious 
interactions when in closer proximity.[27]
The complexes were evaluated for their antimicrobial activity 
in two strains of gram-positive S. aureus, wild type SA01 and 
drug resistant mutant SA02. The minimum inhibitory con-
centration (MIC) of the complexations was assessed through 
a broth microdilution assay, using the free drug (from 2% 
DMSO) and bare polymers as controls. After 24 h incuba-
tion, it can be seen that the complexes had a superior ability 
to inhibit the growth of bacteria in comparison to the free 
drug (Table  2). This effect is particularly heightened for the 
100 mol% macromonomer complexes, which is likely the result 
of the increased drug loading. Interestingly, the HBs comprised 
of the block copolymer structure, whether copolymerized with 
PEGMA or not, display greater antimicrobial performance than 
their random copolymer counterparts. For example, HB7-UA 
and HB8-UA have MIC values of 8 and 4 against SA01 and 
SA02 respectively, whereas HB3-UA and HB4-UA are increased 
to 31 and 16 respectively. Considering that the drug loading of 
these complexes were comparable (≈1:2 HB:UA), this is poten-
tially an effect of the higher density of charged groups and com-
plexed drug towards the periphery of the HB particles, facili-
tating more rapid and complete drug release.[32,33]
Finally, to verify the suitability of the complexes for potential 
in vivo drug delivery applications, the nondrug loaded (posi-
tively charged) HBs were assessed for their cytotoxicity and cell 
membrane integrity using A549 lung cancer cells as a model 
cell line. The cells were incubated with the bare polymer par-
ticles at a single fixed concentration of 250 µg mL−1 (above the 
highest MIC value) for 48 h. It can be seen in Figure 3 that, 
despite the presence of charged amine groups, all eight HBs 
showed no signs of cytotoxicity in both assays, with no decrease 
in cellular metabolic activity or membrane disruption, as indi-
cated by a lack of LDH release.[34]
Overall, the data in this study show that well-defined hyper-
branched polymers can be produced exploiting versatile and 
Macromol. Rapid Commun. 2020, 2000190
Figure 2. A) Removal of Boc-protecting groups using TFA, B) 1H NMR spectrum confirming the appearance of the ammonium peak at 8.5 ppm, and 
C) photograph of aqueous suspensions of drug alone, complexed drug and HB alone, highlighting the increase in drug solubility as a result of HB 
complexation.
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controllable synthetic routes, with few steps and minimal puri-
fications. Therefore, this work has demonstrated a straightfor-
ward route to highly functionalized, biodegradable materials 
which show promise for a variety of therapeutic applications.
In conclusion, we describe the synthesis and evaluation of 
antimicrobial hyperbranched polymer complexes using a com-
bined ROP and RAFT strategy. Unimolecular, highly branched 
nanoparticles were obtained featuring biodegradable and func-
tionalizable monomeric repeat units, with the inclusion of a 
Boc-protected polycarbonate moiety to facilitate the complexa-
tion of the poorly water-soluble drug usnic acid through elec-
trostatic interactions. The resultant polymer–drug complexes 
showed powerful antimicrobial activity towards two strains 
of S. aureus, dependent on the chemistry of the polymer par-
ticles and the arrangement of the charged amine groups in 
the polymer chains. Overall, HBs comprised from a block 
copolymer macromonomer structure showed the greatest 
drug delivery performance, likely as a result of the higher den-
sity of drug molecules on the periphery of the polymer parti-
cles. Despite the presence of charged amine groups, the bare 
polymer particles showed no cytotoxicity or cell membrane 
damage in a model cancer cell line, highlighting the suitability 
of the HBs for in vivo biological applications. Therefore, this 
work has demonstrated a straightforward, versatile, and highly 
accessible route to the formation of polymer-drug complexes 
without the need for additional excipients.
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Figure 3. Cytocompatibility of deprotected HBs on A549 (lung carcinoma) cells. Cytotoxicity was determined by A) PrestoBlue metabolic activity and 
B) LDH release as an indicator of membrane damage. Data are presented as mean ± SD (n = 4).
Table 2. Drug complexation characterization and antimicrobial evaluation.
Sample Structure of macromonomer Usnic acid complexation MIC [µg mL−1]
Drug content (wt%) Encapsulation efficiency (%EE) SA01 SA02
Usnic acida) – – – 250 125
HB1-UA Random 2.34 18.99 125 63
HB2-UA Random 4.12 33.48 125 63
HB3-UA Random 32.63 26.53 31 16
HB4-UA Random 37.31 30.33 31 16
HB5-UA Block 3.64 29.55 63 31
HB6-UA Block 6.19 50.30 63 31
HB7-UA Block 45.88 37.29 8 4
HB8-UA Block 50.85 41.34 8 4
a)from DMSO.
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